Related Experiment Video
Updated: Aug 19, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Abstract:
Twenty-three new biological drugs and diagnostic agents reached their first markets in 2004. The oncolytic drugs therapeutic group was the most active in terms of new launches, with seven market introductions, and the United States was the most active single market for new products, with a total of 10 new launches in 2004.
Insights
In 2004, 23 new biological drugs and diagnostic agents were launched. Oncolytic drugs led new product introductions, with the United States being the primary market.
Area of Science:
- Pharmaceuticals
- Biotechnology
- Medical Diagnostics
Background:
- The year 2004 saw significant activity in the pharmaceutical and biotechnology sectors.
- New biological drugs and diagnostic agents represent advancements in healthcare.
Purpose of the Study:
- To analyze the market introduction of new biological drugs and diagnostic agents in 2004.
- To identify key therapeutic areas and geographical markets for these new products.
Main Methods:
- Data collection on new market launches of biological drugs and diagnostic agents.
- Categorization of products by therapeutic group and geographical market.
Main Results:
- Twenty-three new biological drugs and diagnostic agents were launched in 2004.
- The oncolytic drugs therapeutic group was the most active, with seven new market introductions.
- The United States was the leading market, with 10 new product launches.
Conclusions:
- 2004 was a notable year for new biological product introductions.
- Oncolytic drugs and the US market were central to these advancements.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:25Drug Classes and Categories
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
01:17Drug Nomenclature
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...